BEYOND AGING : THE HIDDEN EPIDEMIC OF SARCOPENIA

Close-up, hands of an elderly woman, an old woman sits with her hands folded.

BEYOND AGING : THE HIDDEN EPIDEMIC OF SARCOPENIA

Sarcopenia is a syndrome characterized by the progressive and generalized loss of skeletal
muscle mass and strength, which can lead to physical disability, poor quality of life, and even
mortality. It is most commonly seen in older adults, though it can affect people at any age,
particularly those with chronic conditions. Following are usually used for diagnosis :

 Low muscle mass: Measured by imaging techniques (e.g., DEXA scan) or other methods
such as bioelectrical impedance analysis.

 Reduced muscle strength: Typically assessed by handgrip strength or other dynamometer tests.

 Low physical performance: This is often evaluated using walking speed or gait speed tests (e.g., the 6-meter walk test).


2. Risk Factors for Sarcopenia:


Non-modifiable Risk Factors:

 Age: The most significant risk factor. Sarcopenia affects almost all adults over the age of

70, with muscle mass decreasing by approximately 3-8% per decade after the age of 30.

 Genetics: Family history may influence the susceptibility to sarcopenia, including

differences in muscle fiber composition and response to physical activity.

 Sex: Women are more likely to experience sarcopenia due to lower baseline muscle mass

and the effects of menopause, which includes decreased levels of estrogen.

 Ethnicity: Certain ethnic groups, such as Asian populations, may have a higher

predisposition to muscle loss compared to others.


Modifiable Risk Factors:

 Physical Inactivity: A sedentary lifestyle is one of the leading contributors to sarcopenia.

Lack of regular resistance exercise or physical activity accelerates muscle atrophy.

 Nutritional Deficiencies: Insufficient intake of protein, vitamin D, and other key

nutrients can accelerate muscle loss. Malnutrition and poor diet, particularly in older

adults, are linked to sarcopenia.

 Chronic Diseases: Conditions like diabetes, cardiovascular disease, chronic kidney

disease, and chronic obstructive pulmonary disease (COPD) are often associated with

muscle wasting.

 Medications: Long-term use of certain medications, such as corticosteroids and other

immunosuppressants, can contribute to muscle degradation.

 Inflammation: Chronic low-grade inflammation, often seen in obesity and metabolic

diseases, can worsen sarcopenia.


3. Management of Sarcopenia:

Effective management of sarcopenia involves addressing the underlying causes and mitigating

the factors that contribute to muscle loss. Key management strategies include:


1. Exercise and Physical Activity:

 Resistance Training: Regular strength training exercises (e.g., weightlifting) are the

cornerstone of sarcopenia management. These exercises stimulate muscle hypertrophy

and improve muscle strength.

 Aerobic Exercise: Cardiovascular activities like walking, cycling, and swimming

improve overall physical performance and contribute to maintaining muscle function.

 Balance and Flexibility Exercises: These exercises reduce the risk of falls and improve

coordination, which is crucial for maintaining functional independence.


2. Nutritional Support:

 Protein Intake: Adequate protein intake is essential to prevent and reverse muscle loss.

Older adults are generally advised to consume 1.2-1.5 grams of protein per kilogram of

body weight per day.

 Vitamin D and Calcium: These are vital for bone and muscle health. Vitamin D plays a

role in muscle function and can be obtained through sunlight exposure or supplements.

 Omega-3 Fatty Acids: These have anti-inflammatory properties and may help in

preserving muscle mass.

 Caloric Intake: Maintaining an appropriate caloric intake to prevent unintentional

weight loss and malnutrition is important.


3. Managing Underlying Conditions:

 Chronic Disease Management: Treating or controlling chronic conditions such as

diabetes, heart disease, or COPD can prevent further muscle loss.

 Medication Review: Reducing or switching medications that contribute to muscle

atrophy (e.g., corticosteroids) should be considered under medical supervision.


4. Fall Prevention and Functional Interventions:

 Assistive Devices: Use of walking aids or modifications in the home environment to

prevent falls and improve mobility.

 Physical Therapy: Rehabilitation programs can help improve strength, mobility, and

reduce the risk of disability.


Conclusion:

Sarcopenia is a multifactorial condition that requires a comprehensive approach to management.

Early detection, regular physical activity, proper nutrition, and addressing underlying health

conditions are crucial for preventing or mitigating the impact of sarcopenia. With an aging global

population, effective management of sarcopenia is becoming increasingly important for

improving health outcomes and maintaining independence in older adults

DR TILAK N

MBBS, MD (INTERNAL MEDICINE),PGDGM(GERIATRICS)

CONSULTANT- INTERNAL MEDICINE